Cue Biopharma, Inc. (CUE) vs Veraxa Biotech AG (VRXA)

Cue Biopharma, Inc. CUE 18.73 +4.00%
Veraxa Biotech AG VRXA 0.95 0.00%

Cue Biopharma, Inc. and Veraxa Biotech AG are both Biotechnology companies. Cue Biopharma, Inc. and Veraxa Biotech AG are of similar size ($140.4M and $136.1M).

Metric	CUE	VRXA	Biotechnology median
P/E	n/m	—	10.60
P/S	3.15	—	9.40
P/B	51.41	—	2.13
Price to free cash flow	n/m	—	25.18
EV/EBITDA	n/m	—	0.66
EV/Sales	2.74	—	9.02
Earnings yield	(143.53%)	—	(32.88%)
Free cash flow yield	(42.21%)	—	(23.13%)

Metric	CUE	VRXA	Biotechnology median
Gross margin	100.00%	—	68.51%
Operating margin	(262.03%)	—	0.00%
Net margin	(435.83%)	—	0.00%
Free cash flow margin	(133.13%)	—	0.00%
Return on equity	(1,603.48%)	—	(51.96%)
Return on assets	(459.60%)	—	(46.06%)
Return on invested capital	0.00%	—	0.00%

Metric	CUE	VRXA	Biotechnology median
Revenue growth (TTM)	354.37%	—	6.76%
EPS growth (last fiscal year)	61.11%	—	29.88%
Revenue growth, 5-year CAGR	54.16%	—	9.75%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	CUE	VRXA	Biotechnology median
Debt to equity	0.00	—	0.00
Current ratio	1.25	—	4.97
Net debt to EBITDA	1.10	—	1.01

Metric	CUE	VRXA	Biotechnology median
Dividend yield	—	—	0.41%
Payout ratio	—	—	—

Metric	CUE	VRXA	Biotechnology median
Market cap	136.06m	140.35m	161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack